FDA Approval For Phase I Trial of Gene-Edited Leukemia Therapeutic

News   Feb 20, 2017

 
FDA Approval For Phase I Trial of Gene-Edited Leukemia Therapeutic
 
 
 
 

RELATED ARTICLES

Advanced Cancer Drug Study Highlights Need for Novel Approaches

News

The pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.

READ MORE

A Unique Amino Acid for Brain Cancer Therapy

News

The taurine-modified photosensitizer created by the OIST research team is a promising new avenue of exploration for enhancing photodynamic therapy for brain cancer.

READ MORE

Existing Drug Found to be Effective at Killing Cancer Stem Cells

News

Study reveals that an existing set of drugs is effective in killing cancer stem cells and explains how this led the team to uncovering important details about how these cells are working in human tumors.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE